Forest Laboratories Inc
Most Recent
Why Tudor sold its position in Forest Laboratories?
Paul Tudor Jones II in 1982 founded Tudor Investment Corporation, which is today a leading asset management firm headquartered in Greenwich, Connecticut. The Tudor Group, consisting of Tudor Investment Corporation and its affiliates, is involved in active trading, investing and research in assets across fixed income, currencies, equities and commodities asset classes and related derivative […]
Why did Tudor buy Intercontinental Exchange?
Paul Tudor Jones II in 1982 founded Tudor Investment Corporation, which is today a leading asset management firm headquartered in Greenwich, Connecticut. The Tudor Group, consisting of Tudor Investment Corporation and its affiliates, is involved in active trading, investing and research in assets across fixed income, currencies, equities and commodities asset classes and related derivative […]
In high spirits? Why did Tudor open position in Beam?
Paul Tudor Jones II in 1982 founded Tudor Investment Corporation, which is today a leading asset management firm headquartered in Greenwich, Connecticut. The Tudor Group, consisting of Tudor Investment Corporation and its affiliates, is involved in active trading, investing and research in assets across fixed income, currencies, equities and commodities asset classes and related derivative […]
Millennium Management adds new position in St. Jude Medical
St. Jude Medical, Inc. is a global medical device company founded in 1976. It has more than 20 principal operations and manufacturing facilities worldwide.
Why Carl Icahn Wants a 100% Stake in Federal-Mogul Holdings
Icahn Enterprises (IEP) has been invested in auto parts maker Federal-Mogul Holdings (FDML) for almost a decade. Carl Icahn currently owns 82% of the company.
Elliott Management starts new position in Cubist Pharmaceuticals
Cubist Pharmaceuticals has grown its pipeline via acquisitions. In 2013, it acquired Trius Therapeutics, obtaining rights to tedizolid phosphate.
Millennium Management decreases position in Northeast Utilities
Northeast Utilities reported a 12% rise in profits on lower operating costs and increased investments in big power transmission projects around New England.
Blue Ridge Capital buys a new position in Actavis
Blue Ridge opened a new position in specialty pharmaceutical company Actavis Plc (ACT) that accounts for 2.27% of the fund’s portfolio.
Thomas Steyer’s Farallon Capital buys a new position in Actavis
Farallon Capital Management opened a new 2.29% stake in specialty pharmaceutical company Actavis PLC (ACT).
